Company intelligence / Profile preview
Gencellmed
- Ownership
- Private
- Development stage
- Preclinical
Overview
Gencellmed develops proprietary oncolytic virus therapies using engineered HSV to selectively target and destroy cancer cells while activating the immune system. The company also commercializes an ADC technology platform and integrates genome analysis/liquid biopsy capabilities. Three patents have been granted related to recombinant herpes simplex viruses expressing fused proteins for targeted cancer therapy, with a focus on immunology and monoclonal antibodies. No published clinical trial results as of the latest data.[1][2][3]
- Therapeutic areas
- Oncology
- Modalities
- Oncolytic viruses (HSV-1 based)Antibody-drug conjugates (ADC platform)[1][3]Gene delivery vectors[2]Liquid biopsy technologies[3]Genome analysis platforms[3]
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Gencellmed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gencellmed.